Replies to post #122451 on Biotech Values

[mcbio]

Dor did the name change to Soligenix SNGX.

Still don't get how they get SNGX out of Soligenix. A bit of a nitpick from me.

Considering the same basic steroid product is now being compounded and used by transplant centers for the same indication, one would think the trial has a good chance of working.

Doesn't it follow that the commercial upside is limited given this practice as well?